OncoTICE® powder for instillation fluid for intravesical use containing 2-8 x 108 CFU Tice BCG. clinical trials

A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer

This study is looking into a new combination treatment for bladder cancer that hasn't spread into the muscle. It combines a standard treatment, BCG, with a new experimental drug called N-803. The aim is to see if this new combination works better at getting rid of the cancer.